Trial Profile
Clinical Trials Insight: 700026208
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 20 Aug 2007
Price :
$35
*
At a glance
- Drugs Cintredekin besudotox (Primary)
- Indications Asthma; Pulmonary fibrosis
- Focus Adverse reactions
- Sponsors NeoPharm Inc
- 20 Aug 2007 New trial record.